Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (KP Pharma) announces a 5 million Euro investment in their Cotia, Brazil facility. KP will expand capacity at its Brazilian location to enable new products to be manufactured in the region.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
“We are seeing substantial growth in our high barrier product segments in South America in response to the increased temperature, moisture and oxygen sensitivity of new drugs. We are excited to support this key mega trend by adding significant capacity and technical capability to support new products into our Cotia facility,” Tracey Peacock, President, Pharmaceutical & Medical Device Films at KP, said.
This latest investment comes about 2 years after the addition of the fourth slitting line in Cotia, which increased the current site’s slitting capacity by ~4.000 tons per year.